Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROI

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on investment. The trailing-twelve-month return on investment at

is 120.50 percent. Nymox Pharmaceutical's revenue for the same period is $2.90 million. The trailing-twelve-month return on investment at

is 66.70 percent. Quotient's gross margin for the same period is 50.50 percent. The trailing-twelve-month return on investment at

is 21.70 percent. Meridian Bioscience's PEG ratio is 1.36. The trailing-twelve-month return on investment at

is 15.60 percent. AMAG Pharmaceuticals' EPS for the same period is $4.40.